Impact of Sociodemographic Factors on Efficacy and Safety of Tofacitinib in Patients with Rheumatoid Arthritis: A Post Hoc Analysis of Phase 2/3/3b/4 Studies

被引：0
|
作者：
Wright, Grace [1 ]
Mysler, Eduardo [2 ]
Roberts, Kevin [3 ]
Sweet, Lindsay [4 ]
Shelbaya, Ahmed [5 ]
机构：
[1] Grace C Wright MD PC, New York, NY USA
[2] Organizac Med Invest, Buenos Aires, DF, Argentina
[3] Pfizer Inc, Cambridge, MA USA
[4] Pfizer Inc, Collegeville, PA USA
[5] Pfizer Inc, New York, NY USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2113
引用
收藏
页码：4172 / 4175
页数：4
相关论文
共 50 条
  • [31] COMPARISON OF TOFACITINIB EFFICACY IN PATIENTS WITH MODERATE VS SEVERE RHEUMATOID ARTHRITIS: POOLED ANALYSIS OF PHASE 3 STUDIES
    Schwartzman, S.
    Sunkureddi, P.
    Takiya, L.
    Snyder, M.
    Fan, H.
    Lukic, T.
    Roberts, J.
    Rigby, W. F. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1202 - 1203
  • [32] Comparison of Tofacitinib Efficacy in Patients with Moderate Vs Severe Rheumatoid Arthritis: Pooled Analysis of Phase 3 Studies
    Schwartzman, Sergio
    Sunkureddi, Prashanth
    Takiya, Liza
    Snyder, Mark
    Fan, Haiyun
    Lukic, Tatjana
    Roberts, Jacqui
    Rigby, William F. C.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [33] Impact of Concomitant Glucocorticoids on the Clinical Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: An Ad Hoc Analysis of Data from Three Phase 3 Studies
    Combe, Bernard
    Buttgereit, Frank
    Ostor, Andrew
    Xavier, Ricardo
    Saraux, Alain
    Daridon, Capucine
    Famulla, Kirsten
    Song, Yanna
    Lagunes-Galindo, Ivan
    Burmester, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [34] IMPACT OF CONCOMITANT GLUCOCORTICOIDS ON THE CLINICAL EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN AD HOC ANALYSIS OF DATA FROM THREE PHASE 3 STUDIES
    Ostor, Andrew
    Combe, Bernard
    Buttgereit, Frank
    Xavier, Ricardo
    Saraux, Alain
    Daridon, Capucine
    Famulla, Kirsten
    Song, Yanna
    Lagunes-Galindo, Ivan
    Burmester, Gert
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 36 - 37
  • [35] IMPACT OF CONCOMITANT GLUCOCORTICOIDS ON THE CLINICAL EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN AD HOC ANALYSIS OF DATA FROM THREE PHASE 3 STUDIES
    Combe, B.
    Buttgereit, F.
    Ostor, A.
    Xavier, R.
    Saraux, A.
    Daridon, C.
    Famulla, K.
    Song, Y.
    Lagunes-Galindo, I.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 567 - 568
  • [36] PREDICTORS OF DURABLE CLINICAL RESPONSE TO TOFACITINIB 11 MG ONCE DAILY WITH OR WITHOUT METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: POST HOC ANALYSIS OF DATA FROM A PHASE 3B/4 METHOTREXATE WITHDRAWAL STUDY
    Yamaoka, K.
    Cohen, S. B.
    Sugiyama, N.
    Shi, H.
    Rivas, J. L.
    Diehl, A.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 563 - 564
  • [37] Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
    Fleischmann, Roy
    Mysler, Eduardo
    Hall, Stephen
    Kivitz, Alan J.
    Moots, Robert J.
    Luo, Zhen
    DeMasi, Ryan
    Soma, Koshika
    Zhang, Richard
    Takiya, Liza
    Tatulych, Svitlana
    Mojcik, Christopher
    Krishnaswami, Sriram
    Menon, Sujatha
    Smolen, Josef S.
    LANCET, 2017, 390 (10093): : 457 - 468
  • [38] Predictors of Durable Clinical Response to Tofacitinib 11 Mg Once Daily with or Without Methotrexate in Patients with Rheumatoid Arthritis: Post Hoc Analysis of Data from a Phase 3b/4 Methotrexate Withdrawal Study
    Yamaoka, Kunihiro
    Cohen, Stanley B.
    Sugiyama, Naonobu
    Shi, Harry
    Rivas, Jose L.
    Diehl, Annette
    Smolen, Josef
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [39] Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3
    Aletaha, Daniel
    Westhovens, Rene
    Gaujoux-Viala, Cecile
    Adami, Giovanni
    Matsumoto, Alan
    Bird, Paul
    Messina, Osvaldo Daniel
    Buch, Maya H.
    Bartok, Beatrix
    Yin, Zhaoyu
    Guo, Ying
    Hendrikx, Thijs
    Burmester, Gerd R.
    RMD OPEN, 2021, 7 (02):
  • [40] Tofacitinib Efficacy/Safety in Patients with Ankylosing Spondylitis by Baseline Body Mass Index: A Post Hoc Analysis of Phase 2/3 Trials
    Hillary Norton
    Paula Sliwinska-Stanczyk
    Tomas Hala
    Bassel El-Zorkany
    Lori Stockert
    Rajiv Mundayat
    Lisy Wang
    Christopher T. Ritchlin
    Rheumatology and Therapy, 2025, 12 (1) : 67 - 84
12345